<abstract xmlns="http://www.w3.org/1999/xhtml"> Background. The ether à go-go (Eag) channel has been shown to be overexpressed in a variety of cancers. However, the expression and function of Eag in osteosarcoma are poorly understood. In addition, the molecular mechanisms responsible for Eag overexpression in cancer cells remain unclear. Methods. The expression of Eag in human osteosarcoma cell line MG-63 was detected by reverse transcription polymerase chain reaction (RT-PCR) and Western blot analysis. The effect of Eag inhibition on MG-63 cell proliferation was assessed <italic>in vitro</italic>. The effect of short hairpin RNA (shRNA) mediated knockdown of Eag on osteosarcoma growth was evaluated in xenograft model <italic>in vivo</italic>. The activation of mitogen-activated protein kinase (MAPK) pathway and p53 in MG-63 cells was detected by Western blot analysis. Results. Eag was overexpressed in MG-63 cells. Imipramine or Eag shRNA significantly suppressed the proliferation of MG-63 cells <italic>in vitro </italic>and <italic>in vivo</italic>. MG-63 cell proliferation was specifically inhibited by p38 MAPK inhibitor SB203580 or small interference RNA (siRNA). The inhibition of p38 MAPK activation by SB203580 or siRNA reduced Eag protein level but increased p53 protein level. Moreover, the activation of p53 by nutlin-3 induced cell growth arrest in MG-63 cells and reduced Eag protein level, while the inactivation of p53 by pifithrin-alpha (PFT-α) promoted MG-63 cell growth and increased Eag protein expression. Conclusions. Eag channel functions as an oncogene to promote the proliferation of human osteosarocma cells. Furthermore, the high expression of Eag in osteosarcoma cells is regulated by p38 MAPK/p53 pathway.</abstract>

Background. The ether à go-go (Eag) channel has been shown to be overexpressed in a variety of cancers. However, the expression and function of Eag in osteosarcoma are poorly understood. In addition, the molecular mechanisms responsible for Eag overexpression in cancer cells remain unclear. Methods. The expression of Eag in human osteosarcoma cell line MG-63 was detected by reverse transcription polymerase chain reaction (RT-PCR) and Western blot analysis. The effect of Eag inhibition on MG-63 cell proliferation was assessed in vitro. The effect of short hairpin RNA (shRNA) mediated knockdown of Eag on osteosarcoma growth was evaluated in xenograft model in vivo. The activation of mitogen-activated protein kinase (MAPK) pathway and p53 in MG-63 cells was detected by Western blot analysis. Results. Eag was overexpressed in MG-63 cells. Imipramine or Eag shRNA significantly suppressed the proliferation of MG-63 cells in vitro and in vivo. MG-63 cell proliferation was specifically inhibited by p38 MAPK inhibitor SB203580 or small interference RNA (siRNA). The inhibition of p38 MAPK activation by SB203580 or siRNA reduced Eag protein level but increased p53 protein level. Moreover, the activation of p53 by nutlin-3 induced cell growth arrest in MG-63 cells and reduced Eag protein level, while the inactivation of p53 by pifithrin-alpha (PFT-α) promoted MG-63 cell growth and increased Eag protein expression. Conclusions. Eag channel functions as an oncogene to promote the proliferation of human osteosarocma cells. Furthermore, the high expression of Eag in osteosarcoma cells is regulated by p38 MAPK/p53 pathway.

p38 MAPK regulates the expression of ether à go-go potassium channel in human osteosarcoma cells

Department of Neurology, the Affiliated Southeast Hospital of Xiamen University, Zhangzhou, China

Department of Thoracic Surgery, the Affiliated Tangdu Hospital of Fourth Military Medical University, Xi’an, China

Department of Orthopaedics, the Affiliated Southeast Hospital of Xiamen University, Zhangzhou, China

Department of Orthopaedics, the Affiliated Southeast Hospital of Xiamen University, Orthopaedic Trauma Center of PLA, Zhanghua Road 269, Zhangzhou, Fujian, China

Radiology and Oncology

Background. The ether à go-go (Eag) channel has been shown to be overexpressed in a variety of cancers. However, the expression and function of Eag in...

p38 MAPK regulates the expression of ether à go-go potassium channel in human osteosarcoma cells

Publicado en línea: 01 feb 2013

Páginas: 42 - 49

DOI: https://doi.org/10.2478/v10019-012-0043-x

Palabras clave
Ether à go-go, cell proliferation, MAPK pathway, p53, osteosarcoma

This content is open access.

p38 MAPK regulates the expression of ether à go-go potassium channel in human osteosarcoma cells

Publicado en línea: 01 feb 2013

Páginas: 42 - 49

DOI: https://doi.org/10.2478/v10019-012-0043-x

Palabras claveEther à go-go, cell proliferation, MAPK pathway, p53, osteosarcoma

This content is open access.

Palabras clave
Ether à go-go, cell proliferation, MAPK pathway, p53, osteosarcoma